In December, the European Society for Medical Oncology (ESMO) published a new clinical practice guideline for...

The health of the thymus is associated with cancer patients’ outcomes to immune checkpoint inhibitor treatment...

The 2025 Gathering Around Cancer, which was the 13th iteration of the conference, brought together national...

New data presented at ESMO 2025 suggests antibody-drug conjugates (ADCs) dramatically improve outcomes for patients with...

BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...

Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...

Stereotactic body radiotherapy (SBRT) is an established treatment for previously unirradiated spinal metastases, however...

First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...

New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...

In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...

In this issue, psilocybin therapy in the HSE, safe prescribing for adult patients with ADHD,and highlights...

Parkinson’s disease (PD) is a common neurodegenerative disorder affecting an estimated 16,000 individuals in Ireland...